Status:
UNKNOWN
AMBULATORY OXIMETRY MONITORING (AOM): a New Approach to Quantify Oxygen Desaturation in Ambulatory COPD Patients
Lead Sponsor:
VA New York Harbor Healthcare System
Conditions:
Pulmonary Disease, Chronic Obstructive
Eligibility:
All Genders
45+ years
Brief Summary
Chronic obstructive lung disease (COPD) is characterized by airflow obstruction that is progressive over many years and is largely irreversible. Advanced COPD is associated with arterial oxygen desatu...
Eligibility Criteria
Inclusion
- Veteran patients with a diagnosis of COPD or other chronic lung disease
- able to read and understand English
- \> 45 years old
- ambulatory and able to perform functional testing
Exclusion
- unable or unwilling to give informed consent
- daily use of a motorized cart
- impairment of cognition or communication
- history of drug or alcohol treatment within the past 6 months
- poor peripheral blood flow to the finger rendering oxygen saturation by pulse oximetry unreliable
- Recent acute medical events (chest pain, discomfort, etc) that would suggest a contraindication to participate at the scheduled time
Key Trial Info
Start Date :
May 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2016
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01873092
Start Date
May 1 2003
End Date
December 1 2016
Last Update
June 7 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA, New York Harbor Healthcare Service
Brooklyn, New York, United States, 11209